Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Foundation for Cardiovascular Research, operating through the Zurich Heart House (ZHH), is a premier non-profit research and educational institution based in Zurich, Switzerland. Founded in 1994 by Professor Thomas F. Lüscher, the foundation bridges the gap between basic science and clinical practice in cardiovascular medicine. It supports the Center for Molecular Cardiology (CMC), which conducts high-impact research into vascular biology, atherosclerosis, and inflammation. The foundation is globally recognized for its role in professional education, hosting international scientific meetings and serving as the editorial base for the European Heart Journal. Through its extensive network of academic and industry partnerships, the foundation facilitates the development and validation of novel diagnostic tools, medical devices, and therapeutic strategies to improve patient outcomes in heart disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foundation for Cardiovascular Research.